NO980751D0 - Substituerte benzylaminopiperidinforbindelser - Google Patents

Substituerte benzylaminopiperidinforbindelser

Info

Publication number: NO980751D0
Authority: NO; Norway
Prior art keywords: compounds; substituted; substituted benzylaminopiperidine; benzylaminopiperidine compounds; benzylaminopiperidine
Prior art date: 1995-08-24

Application number

NO980751A

Other languages

English (en)

Other versions

NO310720B1 (no

NO980751L (no

Inventor

Kunio Satake

Yuji Shishido

Hiroaki Wakabayashi

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-24

Filing date

1998-02-23

Publication date

1998-02-23

1998-02-23 Application filed by Pfizer filed Critical Pfizer

1998-02-23 Publication of NO980751L publication Critical patent/NO980751L/no

1998-02-23 Publication of NO980751D0 publication Critical patent/NO980751D0/no

2001-08-20 Publication of NO310720B1 publication Critical patent/NO310720B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO19980751A 1995-08-24 1998-02-23 Substituerte benzylaminopiperidinforbindelser og farmasöytisk preparat derav NO310720B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB9500683		1995-08-24
PCT/IB1996/000572 WO1997008144A1 (en)	1995-08-24	1996-06-10	Substituted benzylaminopiperidine compounds

Publications (3)

Publication Number	Publication Date
NO980751L NO980751L (no)	1998-02-23
NO980751D0 true NO980751D0 (no)	1998-02-23
NO310720B1 NO310720B1 (no)	2001-08-20

Family

ID=11004362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19980751A NO310720B1 (no)	1995-08-24	1998-02-23	Substituerte benzylaminopiperidinforbindelser og farmasöytisk preparat derav

Country Status (42)

Country	Link
US (1)	US6506775B1 (no)
EP (2)	EP1114817B1 (no)
JP (1)	JP3084069B2 (no)
KR (1)	KR100288673B1 (no)
CN (1)	CN1153764C (no)
AP (1)	AP643A (no)
AR (1)	AR006305A1 (no)
AT (2)	ATE258166T1 (no)
AU (1)	AU702698B2 (no)
BG (1)	BG64126B1 (no)
BR (1)	BR9609989A (no)
CA (1)	CA2227814C (no)
CO (1)	CO4480738A1 (no)
CZ (1)	CZ297543B6 (no)
DE (2)	DE69616817T2 (no)
DK (2)	DK0861235T3 (no)
DZ (1)	DZ2086A1 (no)
ES (2)	ES2163017T3 (no)
HK (1)	HK1014935A1 (no)
HR (1)	HRP960386B1 (no)
HU (1)	HU225480B1 (no)
IL (1)	IL119078A (no)
IS (1)	IS1947B (no)
MA (1)	MA23961A1 (no)
MX (1)	MX9801467A (no)
MY (1)	MY114800A (no)
NO (1)	NO310720B1 (no)
NZ (1)	NZ308207A (no)
OA (1)	OA10666A (no)
PE (2)	PE20010700A1 (no)
PL (1)	PL186773B1 (no)
PT (2)	PT861235E (no)
RO (1)	RO119299B1 (no)
RU (1)	RU2152930C2 (no)
SI (2)	SI1114817T1 (no)
SK (1)	SK282925B6 (no)
TN (1)	TNSN96107A1 (no)
TR (1)	TR199800300T1 (no)
TW (1)	TW340842B (no)
UA (1)	UA48981C2 (no)
WO (1)	WO1997008144A1 (no)
YU (1)	YU49122B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9706196A (es) *	1996-08-14	1998-02-28	Pfizer	Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p.
TW426667B (en) *	1997-11-19	2001-03-21	Pfizer	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
US6777428B1 (en)	1999-02-10	2004-08-17	Eli Lilly And Company	5-HT1f agonist
HUP0201135A3 (en) *	1999-05-06	2003-05-28	Pfizer Prod Inc	Substituted benzolactam compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
RS49964B (sr)	1999-05-17	2008-09-29	Pfizer Products Inc.,	Postupak za dobijanje 2-fenil-3-aminopiridina,njegovih supstituisanih fenil derivata, i njegovih soli
ES2190781T3 (es) *	1999-05-21	2003-08-16	Pfizer Prod Inc	Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
JP2001172178A (ja) *	1999-10-25	2001-06-26	Pfizer Prod Inc	偏頭痛治療用のｎｋ−１レセプターアンタゴニスト及びエレトリプタン
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (en) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist
US6911544B2 (en)	2002-10-23	2005-06-28	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
AU2004232799A1 (en)	2003-04-18	2004-11-04	Eli Lilly And Company	(Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HT1F agonists
JP2008500382A (ja) *	2004-05-21	2008-01-10	ファイザー・プロダクツ・インク	（＋）−（２ｓ，３ｓ）−３−（２−メトキシ−５−トリフルオロメトキシベンジルアミノ）−２−フェニル−ピペリジンの代謝産物
GEP20094640B (en)	2004-07-15	2009-03-10	Bristol Myers Squibb Co	Aryl-and heteroaryl-substituted tetrahydro isoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP1888050B1 (en)	2005-05-17	2012-03-21	Merck Sharp & Dohme Ltd.	cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid for the treatment of cancer
CN101495184A (zh)	2005-07-15	2009-07-29	Amr科技公司	芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用
BRPI0616463A2 (pt)	2005-09-29	2011-06-21	Merck & Co Inc	composto, composição farmacêutica, e, uso de um composto
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
EP2946778A1 (en)	2006-09-22	2015-11-25	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CA2674436C (en)	2007-01-10	2012-07-17	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
CA2682727C (en)	2007-04-02	2016-03-22	Banyu Pharmaceutical Co., Ltd.	Indoledione derivative
WO2009002495A1 (en)	2007-06-27	2008-12-31	Merck & Co., Inc.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
CA2717509A1 (en)	2008-03-03	2009-09-11	Tiger Pharmatech	Tyrosine kinase inhibitors
US7951822B2 (en)	2008-03-31	2011-05-31	Kowa Company, Ltd.	1,3-dihydroisobenzofuran derivatives
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
EP2413932A4 (en)	2009-04-01	2012-09-19	Merck Sharp & Dohme	INHIBITORS OF AKT ACTIVITY
WO2010132487A1 (en)	2009-05-12	2010-11-18	Bristol-Myers Squibb Company	CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
US8802696B2 (en)	2009-05-12	2014-08-12	Albany Molecular Research, Inc.	7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof
MX2011011901A (es)	2009-05-12	2012-01-20	Albany Molecular Res Inc	Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
JP5099731B1 (ja)	2009-10-14	2012-12-19	メルク・シャープ・アンド・ドーム・コーポレーション	ｐ５３活性を増大する置換ピペリジン及びその使用
US8999957B2 (en)	2010-06-24	2015-04-07	Merck Sharp & Dohme Corp.	Heterocyclic compounds as ERK inhibitors
CN103068980B (zh)	2010-08-02	2017-04-05	瑟纳治疗公司	使用短干扰核酸（siNA）的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1（CTNNB1）基因表达的抑制
WO2012024170A2 (en)	2010-08-17	2012-02-23	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP2608669B1 (en)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en)	2010-09-01	2012-03-08	Schering Corporation	Indazole derivatives useful as erk inhibitors
EP2615916B1 (en)	2010-09-16	2017-01-04	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel erk inhibitors
DK2632472T3 (en)	2010-10-29	2018-03-19	Sirna Therapeutics Inc	RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA)
WO2012087772A1 (en)	2010-12-21	2012-06-28	Schering Corporation	Indazole derivatives useful as erk inhibitors
US20140045847A1 (en)	2011-04-21	2014-02-13	Piramal Enterprises Limited	Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
WO2013063214A1 (en)	2011-10-27	2013-05-02	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
WO2013165816A2 (en)	2012-05-02	2013-11-07	Merck Sharp & Dohme Corp.	SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
WO2014052563A2 (en)	2012-09-28	2014-04-03	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
RU2660349C2 (ru)	2012-11-28	2018-07-05	Мерк Шарп И Доум Корп.	Композиции и способы для лечения злокачественной опухоли
EP2935263B1 (en)	2012-12-20	2018-12-05	Merck Sharp & Dohme Corp.	Substituted imidazopyridines as hdm2 inhibitors
EP2951180B1 (en)	2013-01-30	2018-05-02	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as hdm2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
WO2018071283A1 (en)	2016-10-12	2018-04-19	Merck Sharp & Dohme Corp.	Kdm5 inhibitors
WO2019094311A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP3706747A4 (en)	2017-11-08	2021-08-04	Merck Sharp & Dohme Corp.	PRMT5 INHIBITORS
US11981701B2 (en)	2018-08-07	2024-05-14	Merck Sharp & Dohme Llc	PRMT5 inhibitors
EP3833668A4 (en)	2018-08-07	2022-05-11	Merck Sharp & Dohme Corp.	PRMT5 INHIBITORS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5232929A (en) *	1990-11-28	1993-08-03	Pfizer Inc.	3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
US5364943A (en) *	1991-11-27	1994-11-15	Pfizer Inc.	Preparation of substituted piperidines
EP0581777A1 (en) *	1991-03-26	1994-02-09	Pfizer Inc.	Stereoselective preparation of substituted piperidines
CA2109613C (en) *	1991-06-20	1996-11-19	John Adams Lowe Iii	Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (en) *	1993-11-17	1995-10-11	Pfizer	Substance P antagonists for the treatment or prevention of sunburn.
EP0655246A1 (en) *	1993-11-30	1995-05-31	Pfizer Inc.	Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
EP0780375B1 (en) *	1995-12-21	2002-09-11	Pfizer Inc.	3-((5-substituted benzyl)amino)-2-phenylpiperidines as substance p antagonists
US5990125A (en)	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer

1996
- 1996-06-04 TW TW085106675A patent/TW340842B/zh active
- 1996-06-10 PL PL96325332A patent/PL186773B1/pl not_active IP Right Cessation
- 1996-06-10 TN TNTNSN96107A patent/TNSN96107A1/fr unknown
- 1996-06-10 DE DE69616817T patent/DE69616817T2/de not_active Expired - Fee Related
- 1996-06-10 DK DK96914375T patent/DK0861235T3/da active
- 1996-06-10 BR BR9609989A patent/BR9609989A/pt not_active Application Discontinuation
- 1996-06-10 AU AU57769/96A patent/AU702698B2/en not_active Ceased
- 1996-06-10 RU RU98102959/04A patent/RU2152930C2/ru not_active IP Right Cessation
- 1996-06-10 JP JP09510015A patent/JP3084069B2/ja not_active Expired - Fee Related
- 1996-06-10 TR TR1998/00300T patent/TR199800300T1/xx unknown
- 1996-06-10 HU HU9901159A patent/HU225480B1/hu not_active IP Right Cessation
- 1996-06-10 EP EP01108350A patent/EP1114817B1/en not_active Expired - Lifetime
- 1996-06-10 EP EP96914375A patent/EP0861235B1/en not_active Expired - Lifetime
- 1996-06-10 NZ NZ308207A patent/NZ308207A/en unknown
- 1996-06-10 CA CA002227814A patent/CA2227814C/en not_active Expired - Fee Related
- 1996-06-10 ES ES96914375T patent/ES2163017T3/es not_active Expired - Lifetime
- 1996-06-10 KR KR1019980701310A patent/KR100288673B1/ko not_active IP Right Cessation
- 1996-06-10 PT PT96914375T patent/PT861235E/pt unknown
- 1996-06-10 SI SI9630670T patent/SI1114817T1/xx unknown
- 1996-06-10 PT PT01108350T patent/PT1114817E/pt unknown
- 1996-06-10 DK DK01108350T patent/DK1114817T3/da active
- 1996-06-10 UA UA98020924A patent/UA48981C2/uk unknown
- 1996-06-10 ES ES01108350T patent/ES2211684T3/es not_active Expired - Lifetime
- 1996-06-10 AT AT01108350T patent/ATE258166T1/de not_active IP Right Cessation
- 1996-06-10 AT AT96914375T patent/ATE208377T1/de not_active IP Right Cessation
- 1996-06-10 CZ CZ0052198A patent/CZ297543B6/cs not_active IP Right Cessation
- 1996-06-10 DE DE69631390T patent/DE69631390T2/de not_active Expired - Fee Related
- 1996-06-10 MX MX9801467A patent/MX9801467A/es active IP Right Grant
- 1996-06-10 SI SI9630374T patent/SI0861235T1/xx unknown
- 1996-06-10 WO PCT/IB1996/000572 patent/WO1997008144A1/en active IP Right Grant
- 1996-06-10 SK SK207-98A patent/SK282925B6/sk not_active IP Right Cessation
- 1996-06-10 RO RO98-00334A patent/RO119299B1/ro unknown
- 1996-06-10 CN CNB961965037A patent/CN1153764C/zh not_active Expired - Fee Related
- 1996-08-15 IL IL11907896A patent/IL119078A/xx not_active IP Right Cessation
- 1996-08-20 AR ARP960104045A patent/AR006305A1/es active IP Right Grant
- 1996-08-21 PE PE2001000276A patent/PE20010700A1/es not_active Application Discontinuation
- 1996-08-21 DZ DZ960130A patent/DZ2086A1/fr active
- 1996-08-21 PE PE1996000625A patent/PE1398A1/es not_active Application Discontinuation
- 1996-08-22 HR HR960386A patent/HRP960386B1/xx not_active IP Right Cessation
- 1996-08-23 MY MYPI96003496A patent/MY114800A/en unknown
- 1996-08-23 YU YU47896A patent/YU49122B/sh unknown
- 1996-08-23 MA MA24339A patent/MA23961A1/fr unknown
- 1996-08-24 AP APAP/P/1996/000850A patent/AP643A/en active
- 1996-08-26 CO CO96045248A patent/CO4480738A1/es unknown
1997
- 1997-12-30 IS IS4644A patent/IS1947B/is unknown
1998
- 1998-02-23 OA OA9800023A patent/OA10666A/en unknown
- 1998-02-23 NO NO19980751A patent/NO310720B1/no unknown
- 1998-02-27 BG BG102288A patent/BG64126B1/bg unknown
- 1998-12-30 HK HK98119203A patent/HK1014935A1/xx not_active IP Right Cessation
2000
- 2000-05-01 US US09/564,398 patent/US6506775B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HRP960386B1 (en)	2002-04-30
DZ2086A1 (fr)	2002-07-22
CN1153764C (zh)	2004-06-16
MX9801467A (es)	1998-05-31
ES2211684T3 (es)	2004-07-16
PE20010700A1 (es)	2001-07-09
UA48981C2 (uk)	2002-09-16
US6506775B1 (en)	2003-01-14
EP1114817B1 (en)	2004-01-21
TR199800300T1 (xx)	1998-06-22
HK1014935A1 (en)	1999-10-08
YU47896A (sh)	1998-12-23
HRP960386A2 (en)	1998-04-30
DE69616817T2 (de)	2002-04-04
IL119078A0 (en)	1996-11-14
PE1398A1 (es)	1998-02-27
SK20798A3 (en)	1999-03-12
NO310720B1 (no)	2001-08-20
CZ297543B6 (cs)	2007-02-07
NO980751L (no)	1998-02-23
AR006305A1 (es)	1999-08-25
OA10666A (en)	2002-11-25
AU702698B2 (en)	1999-03-04
YU49122B (sh)	2004-03-12
IL119078A (en)	2003-11-23
TW340842B (en)	1998-09-21
JPH10510554A (ja)	1998-10-13
NZ308207A (en)	1998-07-28
BG102288A (en)	1998-09-30
CA2227814A1 (en)	1997-03-06
JP3084069B2 (ja)	2000-09-04
PT861235E (pt)	2002-03-28
BG64126B1 (bg)	2004-01-30
DE69631390D1 (de)	2004-02-26
HU225480B1 (en)	2006-12-28
BR9609989A (pt)	1999-07-06
CA2227814C (en)	2002-12-31
PT1114817E (pt)	2004-05-31
CZ52198A3 (cs)	1999-01-13
IS4644A (is)	1997-12-30
DK0861235T3 (da)	2001-12-27
CN1193961A (zh)	1998-09-23
IS1947B (is)	2004-10-13
KR19990044077A (ko)	1999-06-25
CO4480738A1 (es)	1997-07-09
PL325332A1 (en)	1998-07-20
SI1114817T1 (en)	2004-06-30
SK282925B6 (sk)	2003-01-09
AP9600850A0 (en)	1996-10-31
ES2163017T3 (es)	2002-01-16
EP1114817A1 (en)	2001-07-11
HUP9901159A3 (en)	2000-05-29
TNSN96107A1 (fr)	2005-03-15
EP0861235A1 (en)	1998-09-02
EP0861235B1 (en)	2001-11-07
KR100288673B1 (ko)	2001-05-02
DE69631390T2 (de)	2004-11-25
ATE258166T1 (de)	2004-02-15
AP643A (en)	1998-04-24
RU2152930C2 (ru)	2000-07-20
MY114800A (en)	2003-01-31
PL186773B1 (pl)	2004-02-27
HUP9901159A2 (hu)	1999-07-28
DK1114817T3 (da)	2004-04-26
ATE208377T1 (de)	2001-11-15
SI0861235T1 (en)	2002-04-30
AU5776996A (en)	1997-03-19
DE69616817D1 (de)	2001-12-13
RO119299B1 (ro)	2004-07-30
WO1997008144A1 (en)	1997-03-06
MA23961A1 (fr)	1997-04-01

Publication	Publication Date	Title
DK1114817T3 (da)	2004-04-26	Substituerede benzylaminopiperidinforbindelser
ID16345A (id)	1997-09-25	Senyawa-senyawa heterosiklik
FI972970A (fi)	1997-09-11	Uusia yhdisteitä
FI20030370A (fi)	2003-03-12	Uusia yhdisteitä
DK0777671T3 (da)	2000-07-24	Spiro-azabicykliske forbindelser
DE59609887D1 (de)	2003-01-02	Substituierte cyanophenyluracile
DE69608259D1 (de)	2000-06-15	Verbunddamenbinde
BR9600251A (pt)	1997-12-23	Composto
DE69630414D1 (de)	2003-11-27	5B4T-Kodierungsschema
NO982566D0 (no)	1998-06-04	Forbindelser
ATA135896A (de)	2001-02-15	Skibob
NO974170D0 (no)	1997-09-09	Polyazacykloalkan-forbindelser
DE59610332D1 (de)	2003-05-15	Substituierte aminouracile
FI970151A (fi)	1997-01-14	Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
BR9601295A (pt)	1998-01-13	Composto
BR9608890A (pt)	1999-06-15	N-metilenotiouréias substituídas
BR9609319A (pt)	1999-07-06	Carbonilaminofeniluracilas substituídas
BR9611576A (pt)	1999-03-30	Composto
ATE198470T1 (de)	2001-01-15	Alkenyl-benzoylguanidine
BR9603376A (pt)	1998-05-12	Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de)	2001-10-25	Substituierte benzylidencyanessigester
ATE240972T1 (de)	2003-06-15	Cyclopeptolide
ID18956A (id)	1998-05-28	Senyawa-senyawa herbisida
DE59607958D1 (de)	2001-11-22	Substituierte phenyluracile
BR1100842A (pt)	2000-04-18	Compostos